Semnur Pharmaceuticals, Denali Capital Acquisition Sign LoI For Proposed Business Combination, Which Provides For Pre-Transaction Equity Value Of Semnur Of Up To $2.0B
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.